A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus

Trial Profile

A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus

Discontinued
Phase of Trial: Phase III

Latest Information Update: 28 Jun 2017

At a glance

  • Drugs Riboflavin (Primary)
  • Indications Keratoconus
  • Focus Registrational; Therapeutic Use
  • Sponsors Avedro
  • Most Recent Events

    • 20 Jun 2017 Status changed from active, no longer recruiting to discontinued.
    • 23 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Mar 2017.
    • 27 Jun 2016 Planned End Date changed from 1 Mar 2016 to 1 Dec 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top